Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,210.00
+20.00 (0.32%)
At close: Nov 13, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 80.39 billion as of November 13, 2026. It is the 28,593rd most valuable company in the world and the 1,376th biggest in South Korea. Its market cap has decreased by 12.16% in one year.
Market Cap
80.39B
Enterprise Value
66.96B
Revenue
n/a
Global Rank
Country Rank
#1,376 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 80.39B, a decrease of -28.72%. That is a compound annual growth rate of -9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 80.39B | -33.87% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 94.00B |
| DongKoo Bio & Pharma | 91.94B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 89.49B |
| KOREA PHARMA | 87.25B |
| Samik Pharmaceutical Company LTD. | 85.98B |
| Cosmax Nbt | 81.40B |
| Sam-A Pharm. | 78.61B |
| H.PIO | 78.18B |